Standard InChI: InChI=1S/C26H28N2O7/c1-32-20-13-16-17(11-19(20)29)25(30)23-15-12-21(33-2)22(34-3)14-18(15)26(31)28(24(16)23)6-4-5-27-7-9-35-10-8-27/h11-14,29H,4-10H2,1-3H3
Standard InChI Key: DIZYBTAYMOFSCR-UHFFFAOYSA-N
Associated Targets(Human)
DNA topoisomerase I 7553 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DU-145 51482 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SN12C 47755 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
OVCAR-3 48710 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
UACC-62 47335 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SF-539 44845 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HCT-116 91556 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HOP-62 47048 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
CWR22R 2180 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Tyrosyl-DNA phosphodiesterase 1 345557 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Mus musculus 284745 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 480.52
Molecular Weight (Monoisotopic): 480.1897
AlogP: 2.67
#Rotatable Bonds: 7
Polar Surface Area: 99.46
Molecular Species: NEUTRAL
HBA: 9
HBD: 1
#RO5 Violations: 0
HBA (Lipinski): 9
HBD (Lipinski): 1
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.31
CX Basic pKa: 6.10
CX LogP: 1.20
CX LogD: 1.13
Aromatic Rings: 3
Heavy Atoms: 35
QED Weighted: 0.43
Np Likeness Score: 0.05
References
1.Cinelli MA, Reddy PV, Lv PC, Liang JH, Chen L, Agama K, Pommier Y, van Breemen RB, Cushman M.. (2012) Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons., 55 (24):[PMID:23215354][10.1021/jm300519w]
2.Roy J, Nguyen TX, Kanduluru AK, Venkatesh C, Lv W, Reddy PV, Low PS, Cushman M.. (2015) DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting., 58 (7):[PMID:25822623][10.1021/jm5018384]
3.Nguyen TX, Abdelmalak M, Marchand C, Agama K, Pommier Y, Cushman M.. (2015) Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors., 58 (7):[PMID:25811317][10.1021/acs.jmedchem.5b00136]